A systematic review of evidence-based treatments for prurigo nodularis
Author:
Funder
Galderma
Novartis
Pfizer
Sanofi
Vanda Pharmaceuticals
Publisher
Elsevier BV
Subject
Dermatology
Reference72 articles.
1. Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden;Ständer;Br J Dermatol,2013
2. Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients;Iking;J Eur Acad Dermatol Venereol,2013
3. Nodular prurigo: metabolic diseases are a common association;Winhoven;Clin Exp Dermatol,2007
4. Prurigo nodularis: picking the right treatment;Saco;J Fam Pract,2015
5. Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis;Harris;J Am Acad Dermatol,1992
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2);JAAD International;2024-09
2. A Fleshy Mystery: Prurigo Nodularis;Cureus;2024-07-22
3. Pruritus, Prurigo and Lichen Simplex;Rook's Textbook of Dermatology;2024-02-20
4. Clinical Characteristics and Treatment Outcomes of Prurigo Nodularis: A Retrospective Study;Journal of Cutaneous Medicine and Surgery;2024-01-28
5. A critical evaluation of nemolizumab for prurigo nodularis;Expert Review of Clinical Immunology;2024-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3